Drugs / Platelets
Platelets
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT01135862 | Jun 2010 → Jun 2011 | traumatic brain injury | Tel-Aviv Sourasky Medical Center | Unknown | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT05634109 | Jan 2023 → Dec 2025 overdue | — | Fundacion Clinica Valle del Lili | Recruiting | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT02721940 | Feb 2012 → Jan 2015 | osteonecrosis | Chinese PLA General Hospital | Unknown | No outcome recorded |
| Comparator or background therapy5 trials | ||||||
| Phase 3 | NCT05638581 Comparator | Jul 2023 → Aug 2026 | — | University of Alabama at Birmingham | Completed | No outcome recorded |
| Phase 3 | NCT04431999 Comparator | Dec 2021 → Oct 2025 | blood coagulation disease | Central Directorate of the Army Health Service | Completed | No outcome recorded |
| Phase 3 | NCT04704869 Background | Jan 2017 → Dec 2021 | — | Bryan Cotton | Completed | Missed primary |
| — | NCT01534117 Comparator | Oct 2009 → Nov 2011 | traumatic brain injury | Chang, Steve S., M.D. | Completed | No outcome recorded |
| — | NCT00699621 Comparator | Jan 2009 → Jul 2014 | intracerebral hemorrhage | University of Oulu | Unknown | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 9 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | platelets | “Severe trauma patients with a life threatening bleeding will be managed with 3 packed red blood cells (PRBCs), 3 lyophilised plasma units and 1 dose of platelets for the 1st.” NCT04431999 ↗7“Participants will receive separated blood components (i.e., units of red cells, plasma, platelets, and cryoprecipitate) co-administered intravenously or intraosseously.” NCT05638581 ↗ “the participant will receive 3 red blood cell units, 3 fresh frozen plasma units, and half of a platelets apheresis, equivalent to 3 platelets units.” NCT05634109 ↗ |
| Known as | Homo sapiens platelet, allogenic | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108632 ↗ |
| Known as | Human platelet, allogenic | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108632 ↗ |
| Known as | Platelets allogenic | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108632 ↗ |
| Known as | Platelets human allogenic | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108632 ↗ |
| Modality | Other / unclassified | “Biological: Transfusion of blood products” NCT05634109 ↗ |
| Route | Other | “local administration of enriched BMMCs, platelets and zoledronic acid” NCT02721940 ↗ |